The new Zenivex® E4 RTU mosquito adulticide formulation contains 4% of the active ingredient Etofenprox, a non-organophosphate, non-carbamate, non-ester pyrethroid. Zenivex® E4 RTU adulticide was designed to give mosquito control professionals operational options when controlling mosquitoes. The oil-based formulation is ready to use for a wide variety of Ultra Low Volume foggers without dilution and can be used in hand, ground, or aerial applications.
Zenivex® E20 from Central Life Sciences is a new adulticide for mosquito abatement professionals who want to provide reliable control of adult mosquito populations. Zenivex® E20 is a low odor formulation that works on contact and has these advantages:
The active ingredient in Zenivex® adulticide is Etofenprox (20% by weight), a unique molecule that is new in the control of adult mosquitoes. The EPA has classified Etofenprox as reduced risk, making Zenivex® products the ideal choice in mosquito adulticides. Etofenprox also has the following advantages:
Etofenprox presents a low toxicity to birds and dried foliar residues are not harmful to honeybees. The following chart shows comparative acute toxicities through LD50 measurement.
*An LD50 is a measure of toxicity. The longer the LD50 bar, the lower the toxicity. Compared to the active ingredient in other leading mosquito control products, Etofenprox, the active ingredient in Zenivex® products, is the least toxic.
Zenivex® adulticide offers a positive environmental profile. Zenivex® E20 and Zenivex® E4 are oil-based formulations for use in Ultra Low Volume (ULV) and do not require dilution. They are ready-to-use for hand, ground or aerial application, and require no aquatic setbacks.